Dr. Russell Zelig Szmulewitz, MD
- Medicare services, 2024
- 738
- Medicare patients, 2024
- 214
- Part D claims, 2024
- 1,237
- Publications
- 13
- Clinical trials
- 1
- Practice address
- 5721 S Maryland Ave, Chicago, IL 60637
- Practice phone
- Call (773) 702-1530
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Comer Children's Hospital - Hyde Park
Chicago, Illinois
Find Dr. Szmulewitz's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Russell Zelig Szmulewitz is a hematologist and oncologist in Chicago, Illinois
Dr. Szmulewitz practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.
Dr. Szmulewitz's NPI, 1508029703, was assigned on July 8, 2008. Dr. Szmulewitz graduated from University of Chicago, Pritzker School of Medicine in 2003. Dr. Szmulewitz holds Illinois license 036-116053.
- NPI
- 1508029703NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7113071192
- NPI enumeration date
- July 8, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (773) 702-1530
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Russell Zelig Szmulewitz practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois
Dr. Szmulewitz's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.
- Comer Children's Hospital - Hyde Park5721 S Maryland Ave, Chicago, IL 60637 · Cook CountyPhone(773) 702-1530
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Russell Zelig Szmulewitz is affiliated with 5 sites of care and 2 medical groups
Dr. Szmulewitz's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dr. Szmulewitz is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Szmulewitz to 3 more hospitals and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Russell Zelig Szmulewitz's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Szmulewitz practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Comer Children's Hospital - Hyde Park | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Russell Zelig Szmulewitz is one of 563 hematologists and oncologists in Illinois
Hematology and oncology is Dr. Szmulewitz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Szmulewitz is licensed in Illinois.
Specialties and state licenses
- Hematology and oncology, IllinoisPrimary
Hematologists and oncologists near Dr. Szmulewitz
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Russell Zelig Szmulewitz billed Medicare for 738 services in 2024
CMS data shows 738 Medicare services from Dr. Szmulewitz across 8 procedure codes in 2024, for 214 Medicare patients. Medicare paid $46,226 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Szmulewitz's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 5472024: 47813%
- Other services
- 2023: 02024: 260
Dr. Szmulewitz compared with the Illinois median for hematologists and oncologists, 2024
- Dr. Szmulewitz
- Illinois median
- Medicare services
- 738vs 1,05630% below
- Medicare patients
- 214vs 28224% below
- Part D claims
- 1,106vs 3283.4 times
Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Szmulewitz's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Szmulewitz?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Szmulewitz and other hematologists and oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Russell Zelig Szmulewitz treated 214 Medicare patients in 2024, average age 74
CMS counts 214 Medicare patients who saw Dr. Szmulewitz in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have cancer, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Szmulewitz's median patient age at 74, with 7% women.
Dr. Szmulewitz's Medicare patients by age, 2024
Dr. Szmulewitz's Medicare patients by sex, 2024
- Women2311%
- Men19189%
Chronic conditions among Dr. Szmulewitz's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis40%
- Ischemic heart disease35%
- Diabetes29%
- Chronic kidney disease28%
- Atrial fibrillation22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Szmulewitz's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women7%
- Men93%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Russell Zelig Szmulewitz wrote 1,237 Medicare Part D claims in 2024
In 2024, Dr. Szmulewitz wrote 1,237 Medicare Part D claims for 152 patients. 72% of them were for generic drugs. CMS names the drug for 1,106 of them, across 12 drugs with 11 or more claims each, at $3,779,661 in total drug cost. In 2023, CMS named 1,123 claims across 12 drugs.
Dr. Szmulewitz's Part D claims by kind of drug, 2024
- Generic896 claims72%
- Brand-name341 claims28%
Dr. Szmulewitz's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Szmulewitz's Part D claims, 2024
- Opioids3%34 of 1,237 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,1232024: 1,1062%
Drugs named by CMS: 12 in 2024, 12 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Russell Zelig Szmulewitz offers telehealth to Medicare patients
Dr. Szmulewitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Szmulewitz as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Russell Zelig Szmulewitz has 13 publications on record
Dmand AI links 13 papers to Dr. Szmulewitz, published from 2023 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Benzamides, Nitriles and Phenylthiohydantoin. Dr. Szmulewitz has published most often in Clin Cancer Res. Dr. Szmulewitz's most frequent co-authors are Stanley L. Liauw, Sean Pravin Pitroda, MD and Randy F. Sweis.
Dr. Szmulewitz's papers by year, 2023 to 2025
Topics Dr. Szmulewitz writes about most
- Benzamides
- Nitriles
- Phenylthiohydantoin
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Biomarkers, Tumor
- Receptors, Androgen
- Androgen Antagonists
Dr. Szmulewitz's most frequent co-authors
Recent publications by Dr. Szmulewitz
See who Dr. Szmulewitz researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Szmulewitz works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Russell Zelig Szmulewitz has worked on 1 clinical trial
Dmand AI links Dr. Szmulewitz to 1 clinical trial. Open Payments lists research payments to Dr. Szmulewitz that name 1 trial.
Investigators on the most trials with Dr. Szmulewitz
- Andrew John Armstrong, MD1 shared trial
- Tomasz M. Beer, MD1 shared trial
- David F. Cella, PhD1 shared trial
Recent clinical trials with Dr. Szmulewitz
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Russell Zelig Szmulewitz received $100,530 in industry payments from 2016 to 2025
CMS Open Payments shows 104 general payments to Dr. Szmulewitz from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Pfizer Inc. paid the most, $15,798. It also lists 191 research payments totaling $50,208 from 2017 to 2025, naming 1 clinical trial.
General payments to Dr. Szmulewitz by program year, 2016 to 2025
General payments to Dr. Szmulewitz by kind, 2016 to 2025
- Consulting fees$74,92675%
- Travel and lodging$11,04911%
- Speaker and faculty fees$7,3107%
- Food and beverage$5,0725%
- Other$2,1732%
Companies that paid Dr. Szmulewitz the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Russell Zelig Szmulewitz graduated from University of Chicago, Pritzker School of Medicine
Dr. Szmulewitz graduated from University of Chicago, Pritzker School of Medicine in 2003.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Russell Zelig Szmulewitz's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Russell Zelig Szmulewitz
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Russell Zelig Szmulewitz's NPI number?
Dr. Russell Zelig Szmulewitz's NPI number is 1508029703. It was assigned on July 8, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Russell Zelig Szmulewitz?
Dr. Russell Zelig Szmulewitz is a hematologist and oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Russell Zelig Szmulewitz practice?
Dr. Szmulewitz practices at 5721 S Maryland Ave, Chicago, IL 60637. Dr. Szmulewitz's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dmand AI also links Dr. Szmulewitz to 3 hospitals and 1 medical group.
What is Dr. Russell Zelig Szmulewitz's office phone number?
The practice phone on file for Dr. Szmulewitz is (773) 702-1530.
What is Dr. Russell Zelig Szmulewitz's medical license number?
Dr. Szmulewitz holds Illinois license 036-116053.
Which hospitals is Dr. Russell Zelig Szmulewitz affiliated with?
Dr. Szmulewitz is affiliated with University of Chicago Medical Center. Dmand AI links Dr. Szmulewitz to 3 more hospitals.
What medical group is Dr. Russell Zelig Szmulewitz part of?
Dr. Szmulewitz is linked to UChicago Medicine Physicians. Dmand AI links Dr. Szmulewitz to 1 more medical group.
Does Dr. Russell Zelig Szmulewitz accept Medicare?
Yes. CMS data shows Dr. Szmulewitz billed Medicare for 738 services in 2024, and Dr. Szmulewitz accepts Medicare assignment.
Does Dr. Russell Zelig Szmulewitz offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Szmulewitz as offering telehealth services.
How many Medicare patients does Dr. Russell Zelig Szmulewitz see?
CMS counts 214 Medicare patients who saw Dr. Szmulewitz in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. Russell Zelig Szmulewitz bill to Medicare?
In 2024, Dr. Szmulewitz's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).
Where did Dr. Russell Zelig Szmulewitz go to medical school?
Dr. Szmulewitz graduated from University of Chicago, Pritzker School of Medicine in 2003.
What drugs does Dr. Russell Zelig Szmulewitz prescribe most?
In 2024 Medicare Part D data, Dr. Szmulewitz's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Xtandi.
Has Dr. Russell Zelig Szmulewitz received payments from drug or device companies?
CMS Open Payments shows $100,530 in general payments to Dr. Szmulewitz from 18 companies from 2016 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Russell Zelig Szmulewitz been practicing?
Dr. Szmulewitz graduated from medical school in 2003, 23 years ago.
Does Dr. Russell Zelig Szmulewitz do research?
Dmand AI links 13 publications to Dr. Szmulewitz, published from 2023 to 2025. Dr. Szmulewitz has worked on 1 clinical trial.
Who does Dr. Russell Zelig Szmulewitz publish with?
Dr. Szmulewitz's most frequent co-authors are Stanley L. Liauw (4 shared papers), Sean Pravin Pitroda, MD (4 shared papers) and Randy F. Sweis (4 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card